OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal 
Italy Investigates Microsoft Over Microsoft 365 AI Subscription Price Hike 
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
Nomura Stock Upgraded to Buy by BofA as Stronger ROE and Earnings Growth Boost Outlook 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
Alphabet Replaces Verizon in Dow Jones Industrial Average 
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Bayer AG has resolved about 88,500 of an estimated 125,000 filed and unfiled claims against its Roundup weedkiller, prompting US court-appointed mediator Kenneth Feinberg to report that the company had made substantial progress.
Feinberg noted that it is just a question of when and how quickly they’ll get resolved.”
The German company said it is fully committed to settling the litigations concerning the carcinogenic properties of Roundup.
Bayer inherited liability for the lawsuits over glyphosate-based Roundup, which it acquired along with its purchase of Monsanto for $63 billion in June 2018.
The acquisition made Bayer the world’s largest supplier of seeds and pesticides but its shares have since fallen 54 percent.
Bayer lost three trials for Roundup in 2018 and 2019.
In June, the company projected it would pay up to $10.9 billion to resolve existing claims and $1.25 billion for future claims. Last week, it increased the projected cost of future claims to $2 billion and took a $10.9 billion writedown in its crop science business.
